Expression Profile as Predictor of Relapse after Adjuvant Treatment in Gastric Cancer
- 1 March 2011
- journal article
- research article
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 43 (2) , 181-189
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- EPO-R Expression Patterns in Resected Gastric Adenocarcinoma Followed by Adjuvant Chemoradiation TreatmentPathology and Oncology Research, 2008
- Amplification of the HER2 gene in breast cancers testing 2+ weak positive by HercepTest immunohistochemistry: false-positive or false-negative immunohistochemistry?Journal of Clinical Pathology, 2007
- Tumour suppressor gene expression correlates with gastric cancer prognosisThe Journal of Pathology, 2003
- Relationship between E‐cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl‐2 expression and Ki‐67 staining in diffuse‐type gastric carcinomaInternational Journal of Cancer, 2003
- Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal JunctionNew England Journal of Medicine, 2001
- Siah-1, SIP, and Ebi Collaborate in a Novel Pathway for β-Catenin Degradation Linked to p53 ResponsesMolecular Cell, 2001
- Excess β‐catenin promotes accumulation of transcriptionally active p53The EMBO Journal, 1999
- Dimeric sialyl-Lex expression in gastric carcinoma correlates with venous invasion and poor outcomeGastroenterology, 1998
- The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agentsInternational Journal of Cancer, 1995
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994